These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7334446)

  • 1. Systemic effects of mydriatics in low weight infants.
    Rosales T; Isenberg S; Leake R; Everett S
    J Pediatr Ophthalmol Strabismus; 1981; 18(6):42-4. PubMed ID: 7334446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.
    Elibol O; Alçelik T; Yüksel N; Caglar Y
    Acta Ophthalmol Scand; 1997 Apr; 75(2):178-80. PubMed ID: 9197568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serious adverse side effects after pupillary dilation in preterm infants].
    Lux AL; Mouriaux F; Guillois B; Fedrizzi S; Peyro-Saint-Paul L; Denion E
    J Fr Ophtalmol; 2015 Mar; 38(3):193-8. PubMed ID: 25726252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Same-eye comparison of pupillary dilation with an intraoperative standardized intracameral combination of mydriatics (Mydrane®) versus a preoperative ophthalmic (Mydriasert®) in standard cataract surgery in non-diabetic patients (French translation of the article)].
    de Faria A; Giorgi R; Cohen Salmon M; Bonnel S; Holweck G; Le Corre A; Chazalon E
    J Fr Ophtalmol; 2019 Dec; 42(10):1068-1077. PubMed ID: 31668379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant.
    Degirmencioglu H; Oncel MY; Calisici E; Say B; Uras N; Dilmen U
    J Pediatr Ophthalmol Strabismus; 2014 Jul; 51 Online():e44-7. PubMed ID: 25003832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides.
    Chew C; Rahman RA; Shafie SM; Mohamad Z
    J Pediatr Ophthalmol Strabismus; 2005; 42(3):166-73. PubMed ID: 15977870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants.
    Lees BJ; Cabal LA
    Pediatrics; 1981 Aug; 68(2):231-4. PubMed ID: 7267230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of mydriatics in low-birth-weight infants.
    Isenberg S; Everett S
    J Pediatr; 1984 Jul; 105(1):111-2. PubMed ID: 6737125
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.
    Bolt B; Benz B; Koerner F; Bossi E
    J Pediatr Ophthalmol Strabismus; 1992; 29(3):157-62. PubMed ID: 1432499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography.
    Cagini C; Caricato A; Tosi G; Pascale A; Cesari C; Fiore T
    Eur J Ophthalmol; 2014; 24(5):728-34. PubMed ID: 24557758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparison of mydriatic effect between two drugs of different mechanism.
    Park JH; Lee YC; Lee SY
    Korean J Ophthalmol; 2009 Mar; 23(1):40-2. PubMed ID: 19337478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupil dilation using phenylephrine alone or in combination with tropicamide.
    Fraunfelder FT
    Ophthalmology; 1999 Jan; 106(1):4. PubMed ID: 9917769
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.
    Alpay A; Canturk Ugurbas S; Aydemir C
    BMC Pediatr; 2019 Nov; 19(1):415. PubMed ID: 31690284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.
    Liu JC; Green W; Van Stavern GP; Culican SM
    Can J Ophthalmol; 2017 Aug; 52(4):349-354. PubMed ID: 28774515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.
    Bhurayanontachai P; Saengkaew S; Apiromruck P
    J Optom; 2017; 10(2):111-116. PubMed ID: 27321772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of mydriatic eyedrops in low-weight infants.
    Isenberg S; Everett S; Parelhoff E
    Ophthalmology; 1984 Mar; 91(3):278-9. PubMed ID: 6546977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular gelfoam disc-applicator for pupillary dilation in humans.
    Negvesky GJ; Butrus SI; Abifarah HA; Lee YC; Yalkowsky SH
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):311-5. PubMed ID: 10977126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.